Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $14.97 USD
Change Today -0.07 / -0.47%
Volume 37.0K
CUTR On Other Exchanges
As of 5:20 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

cutera inc (CUTR) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/29/15 - $16.37
52 Week Low
08/5/14 - $8.80
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CUTERA INC (CUTR)

cutera inc (CUTR) Related Bloomberg News

View More Bloomberg News

cutera inc (CUTR) Related Businessweek News

No Related Businessweek News Found

cutera inc (CUTR) Details

Cutera, Inc., a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems for practitioners worldwide. It offers products based on platforms, such as xeo, a multi-application platform on which a customer can purchase hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin rejuvenation by treating discoloration, improving texture, reducing pore size, and treating fine lines and laxity; and Genesis Plus, a laser system for performing aesthetic skin procedures and for the temporary increase of clear nail in patients with onychomycosis, or toenail fungus. This system is also used to treat skin concerns, such as fine wrinkles, diffuse redness, and rosacea; and excel V, a vascular platform that treats the entire range of cosmetic vascular conditions. The company also offers truSculpt, a radio frequency platform designed for the non-invasive body contouring market; excel HR, a hair removal solution for various skin types; and enlighten, a laser system for tattoo removal and the treatment of benign pigmented lesions. In addition, its products include CoolGlide, Solera, and a third-party sourced system, myQ for the Japanese market. Further, the company provides post-warranty services through extended service contracts or direct billing; and sells Titan hand piece refills and marketing brochures through the Internet, as well as dermal fillers and cosmeceuticals. It markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, primary care physicians, family practitioners, and physicians offering aesthetic treatments in non-medical offices, podiatrists, and other qualified practitioners. Cutera, Inc. was founded in 1998 and is headquartered in Brisbane, California.

266 Employees
Last Reported Date: 03/16/15
Founded in 1998

cutera inc (CUTR) Top Compensated Officers

Chief Executive Officer, President and Execut...
Total Annual Compensation: $907.5K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $504.3K
Compensation as of Fiscal Year 2014.

cutera inc (CUTR) Key Developments

Cutera, Inc.(NasdaqGS:CUTR) added to Russell 2000 Index

Cutera, Inc. will be added to Russell 2000 Index

Cutera, Inc.(NasdaqGS:CUTR) added to Russell 3000 Index

Cutera, Inc. will be added to the Russell 3000 Index.

Cutera, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for Second Quarter, Third Quarter, Fourth Quarter and Full Year of 2015

Cutera, Inc. announced unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported net revenue of $19,071,000 against $16,189,000 a year ago. The company estimated the negative revenue impact associated with the appreciation of the U.S. dollar to be in the range of $1 million to $1.5 million for the quarter. Loss from operations was $3,602,000 against $3,653,000 a year ago. Loss before income tax was $3,594,000 against $3,573,000 a year ago. Net loss was $3,644,000 or $0.25 per basic and diluted share against $3,610,000 or $0.26 per basic and diluted share a year ago. Net cash used in operating activities was $6,014,000 against $972,000 a year ago. Acquisition of property, equipment and software were $407,000 against $239,000 a year ago. The company reported no debt for the quarter. The company expects revenue growth to continue and to be in the range of 15% to 20% year-over-year in each of the remaining three quarters of 2015. The company expects the second, third and fourth quarter 2015 gross margins to be in the range of 55%, 57% and 59%, respectively. The company expects quarterly R&D spending to be in the $2.5 million range for the remainder of 2015. For the remainder of the 2015, the company expects quarterly G&A expense to be approximately $3 million. The company expects to generate cash from operations in the remaining three quarters of the year.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CUTR:US $14.97 USD -0.07

CUTR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
El.En. SpA €40.74 EUR +0.44
Lutronic Corp 54,800 KRW -4,600.00
PhotoMedex Inc $1.07 USD +0.05
Valeant Pharmaceuticals International Inc C$329.79 CAD -4.12
Zeltiq Aesthetics Inc $31.76 USD -0.52
View Industry Companies

Industry Analysis


Industry Average

Valuation CUTR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.7x
Price/Book 2.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CUTERA INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at